PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsPulmonary hypertension
MeSH D006976 - pulmonary hypertension
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008171:Lung diseases
3 Companies
2 Drugs
$
Success rate
D006973:Hypertension
242 Companies
95 Drugs
$
Success rate
D006976: 
Pulmonary hypertension
101 Companies
21 Drugs
$
Success rate
D000081029:Pulmonary arterial hypertension
0 Companies
0 Drugs
Success rate
D010547:Persistent fetal circulation syndrome
1 Company
1 Drug
$
Success rate
D065627:Familial primary pulmonary hypertension
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AbbVieNitroglycerin Rectiv  2011-06-21   
Accord HealthcareSildenafil Granpidam  2016-11-14   
Tadalafil Tadalafil  2019-03-26   
ActelionMacitentan Opsumit 2025-12-05 2013-10-18   
Bosentan Tracleer  2001-11-20   
Selexipag Uptravi 2026-10-31 2015-12-21   
Epoprostenol Veletri 2027-02-02 2008-06-27   
Iloprost Ventavis  2004-12-29   
Ajanta PharmaSildenafil Sildenafil  2018-10-12   
Tadalafil Tadalafil  2019-03-26   
Alembic PharmaceuticalsBosentan Bosentan  2020-01-23   
Tadalafil Tadalafil  2019-03-26   
Selexipag Selexipag  2023-10-11   
Treprostinil Treprostinil  2021-02-11   
Alkem LaboratoriesSildenafil Sildenafil  2019-11-27   
AllerganAmbrisentan Ambrisentan  2019-03-28   
Bosentan Bosentan  2019-04-26   
Hydrochlorothiazide, Hydralazine Hydralazine Hydrochlorothiazide  1982-03-04   
Hydrochlorothiazide, Hydralazine, Reserpine Hydralazine, Hydrochlorothiazide W/ Reserpine  1982-01-01   
Hydrochlorothiazide, Hydralazine Hydrochlorothiazide W/ Hydralazine  1982-01-01   
Hydrochlorothiazide, Hydralazine, Reserpine Hydrochlorothiazide W/ Reserpine Hydralazine  1982-01-01   
Nitroglycerin Nitroglycerin  2017-10-16   
Hydrochlorothiazide, Hydralazine, Reserpine Reserpine, Hydralazine Hydrochlorothiazide  1982-01-01   
Sildenafil Sildenafil  2013-02-25   
Sildenafil Sildenafil Actavis  2009-12-10   
Tadalafil Tadalafil  2019-03-29   
AlvogenBosentan Bosentan  2019-04-26   
American RegentNitroglycerin Nitroglycerin  1988-05-24   
Amneal PharmaceuticalsBosentan Bosentan  2019-04-26   
Sildenafil Sildenafil  2018-06-27   
Tadalafil Tadalafil  2019-03-26   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
54%
19/35
Phase 2
40%
20/50
Phase 3
75%
41/55
Approved: 24Overall Success rate: 16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Actelion
Tadalafil,
Selexipag,
Macitentan,
Bosentan monohydrate,
Iloprost,
Bosentan,
Epoprostenol,
Salicylic acid,
Tezosentan
Allergan
Hydrochlorothiazide
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use